The case for and the case against Pharvaris N.V., each point drawn from public SEC filings — who’s buying, the red flags, and the health score. No opinion, no price call. Read both sides, then pick yours.
the bull case // 0
No recent buying across insiders, Congress, or 13F filers, and no standout strength in the filing-based scores. A quiet bull case — not the same as a bear case.
the bear case // 3
Active dilution shelf
An effective S-3 shelf with 1 prospectus filing(s) in 12 months — shares may be getting sold into the market.
One-sided insider selling
9 insider sales and no open-market buys in the recent window, not counting 7 made under a Rule 10b5-1 plan.
Insiders are selling
9 insider sales recently with no offsetting open-market buys, not counting 7 made under a Rule 10b5-1 plan.
Share this debateSend the PHVS bull vs bear case — free, straight from the filings.
Educational only — not financial advice and never a recommendation to buy or sell. Both sides are built from public SEC filings (Form 4, STOCK Act, 13F, XBRL financials), which lag 40–90 days; absence of a red flag is not a clean bill of health.